ECSP088079A - ORAL FORMULATIONS THAT INCLUDE ONDANSETRON AND A HIGHLY DOSED EDULCORANT - Google Patents
ORAL FORMULATIONS THAT INCLUDE ONDANSETRON AND A HIGHLY DOSED EDULCORANTInfo
- Publication number
- ECSP088079A ECSP088079A EC2008008079A ECSP088079A ECSP088079A EC SP088079 A ECSP088079 A EC SP088079A EC 2008008079 A EC2008008079 A EC 2008008079A EC SP088079 A ECSP088079 A EC SP088079A EC SP088079 A ECSP088079 A EC SP088079A
- Authority
- EC
- Ecuador
- Prior art keywords
- edulcorant
- oral formulations
- highly dosed
- include ondansetron
- ondansetron
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención proporciona composiciones farmacéuticas de administración oral, caracterizadas por contener sales solubles de ondansetrón y edulcorantes con alto poder endulzante, en proporciones elevadas en relación con el ingrediente activo.The present invention provides oral administration pharmaceutical compositions, characterized in that they contain soluble salts of ondansetron and sweeteners with high sweetening power, in high proportions in relation to the active ingredient.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0502736-5A BRPI0502736A (en) | 2005-07-05 | 2005-07-05 | oral formulations of masked residual flavor ondansetron |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088079A true ECSP088079A (en) | 2008-02-20 |
Family
ID=37604052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008079A ECSP088079A (en) | 2005-07-05 | 2008-01-04 | ORAL FORMULATIONS THAT INCLUDE ONDANSETRON AND A HIGHLY DOSED EDULCORANT |
Country Status (3)
Country | Link |
---|---|
BR (1) | BRPI0502736A (en) |
EC (1) | ECSP088079A (en) |
WO (1) | WO2007003020A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1401086B1 (en) * | 2010-07-19 | 2013-07-12 | Farmalip S R L | SWEETENER. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10109763A1 (en) * | 2001-02-28 | 2002-09-05 | Gruenenthal Gmbh | Pharmaceutical salts |
AU2002255196A1 (en) * | 2002-04-18 | 2003-10-27 | Dr. Reddy's Laboratories Ltd. | Rapidly dispersing solid oral compositions |
-
2005
- 2005-07-05 BR BRPI0502736-5A patent/BRPI0502736A/en not_active Application Discontinuation
-
2006
- 2006-02-06 WO PCT/BR2006/000015 patent/WO2007003020A1/en active Application Filing
-
2008
- 2008-01-04 EC EC2008008079A patent/ECSP088079A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0502736A (en) | 2007-02-27 |
WO2007003020A1 (en) | 2007-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011000589A1 (en) | Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer. | |
MY157772A (en) | Antibody formulation | |
EA201290984A1 (en) | PHARMACEUTICAL PHARMACEUTICAL COMPOSITIONS, PREVENTING ABUSE | |
BRPI0506779A (en) | Ice cream formulation and ice cream | |
CR20110110A (en) | PHARMACEUTICAL COMPOSITION | |
HN2011003011A (en) | SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM | |
AR080491A1 (en) | ORAL FORMULATIONS AND LIPOFILIC SALTS OF METHYLNTREXONE | |
NO20080220L (en) | Formulations with high drug loading and dosage forms | |
NO20075111L (en) | Pharmaceutical composition | |
MY161595A (en) | Oral care compositions | |
HN2003000206A (en) | PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO | |
EA201170512A1 (en) | COMPOSITION FOR ORAL ADMINISTRATION | |
TR200900878A2 (en) | Pharmaceutical formulations combined in a single dosage form | |
NO20073026L (en) | 2-Alkoxy-3,4,5-trihydroxyalkylamides, preparation and compositions thereof, and use thereof | |
ECSP10010576A (en) | ORAL AND INJECTABLE FORMULATIONS OF TETRACICLINE COMPOUNDS | |
CY1109537T1 (en) | Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION | |
IN2012DN00359A (en) | ||
UY31758A (en) | ORVEPITANT MALEATE ANHYDRA CRYSTAL FORM | |
MX2010004899A (en) | Novel neurturin conjugates for pharmaceutical use. | |
TR200806300A2 (en) | Solubility enhancing pharmaceutical formulation | |
TR200900879A2 (en) | Pharmaceutical compositions in which the active ingredients are combined in a single dosage form | |
GT200800297A (en) | GALENIC FORMULATIONS OF ALISQUIRENO AND HYDROCLOROTIAZIDA | |
CO6321223A2 (en) | SOLID PHARMACEUTICAL FORMULATION CONTAINING CYCLOSTAZOL | |
BRPI0510820A (en) | pharmaceutical composition, unit dosage form and its uses | |
UY29989A1 (en) | PHARMACEUTICAL COMPOSITIONS OF HYPNOTIC AGENTS OF SHORT ACTION IN THE FORM OF A MODIFIED RELEASE AND PROCEDURES TO PREPARE SUCH FORMULATIONS |